Pituitary Diseases
14
1
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
50%
7 trials in Phase 3/4
56%
5 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Long Term Outcome Study in Patients With Pituitary Disorders
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas
Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency
Lipolytic Effects of GH in Hypopituitary Patients in Vivo
Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
Peri-Operative Steroid Management in Patients
The Cardiovascular Changes Associated With Septal Local Anaesthesia
Prognosis of Atypical Pituitary Adenomas